Vimarsana
Biggest News Aggregation in the World

Page 20 - Major Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Major Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Major Project Today - Breaking & Trending Today

Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022 - Vimarsana News

Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022

Published: March 9, 2022

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
Hong KongUnited StatesWestern AustraliaAscentage PharmaMajor NationalMd Anderson Cancer CenterNational Major New Drug DiscoveryChina National Medical Products AdministrationAmerican Association For Cancer ResearchDana Farber Cancer InstituteAmerican AssociationCancer ResearchAnnual MeetingNew OrleansMolecular TherapeuticsPediatric MalignancySarcoma Treatment ResistanceCellular BiologyNon Apoptotic Cell DeathSmall Molecule Therapeutic AgentsCell CycleReplication InhibitorsEmerging New Anticancer AgentsSignaling Pathway InhibitorsMain Board
Resources Top 5: Lithium, rare earths, and a 'Major' cobalt project - Vimarsana News

Resources Top 5: Lithium, rare earths, and a 'Major' cobalt project

Published: March 2, 2022

Resources Top 5: Lithium, rare earths, and a ‘Major’ cobalt project

Source: stockhead.com.au
Related Topics:
Broken HillNew South WalesCopper HillSouth AustraliaJeneta OwensJoe KaderavekInternational Lithium CorpBroken Hill Cobalt ProjectMajor ProjectWednesday MarchInternational LithiumMajor Project StatusAustralian GovernmentCopper HillMacquarie ArcChina MolybdenumEvolution Mining
Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma - Vimarsana News

Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma

Published: January 12, 2022

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
United StatesHong KongWestern AustraliaInnovent BiologicsDajun YangAscentage PharmaMajor NationalAmerican Society Of Clinical OncologyEuropean CommissionDrug AdministrationMd Anderson Cancer CenterAmerican Society Of HematologyNational Major New Drug DiscoveryChina National Medical Products AdministrationDana Farber Cancer InstituteHealthcare ConferenceBeijing TimeClinical OncologyAnnual MeetingMain BoardStock ExchangeHong Kong LimitedPriority ReviewBreakthrough Therapy DesignationDrug Evaluation
Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma - Vimarsana News

Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma

Published: January 12, 2022

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
United StatesHong KongWestern AustraliaInnovent BiologicsDajun YangAscentage PharmaMajor NationalAmerican Society Of Clinical OncologyEuropean CommissionDrug AdministrationMd Anderson Cancer CenterAmerican Society Of HematologyNational Major New Drug DiscoveryChina National Medical Products AdministrationDana Farber Cancer InstituteHealthcare ConferenceBeijing TimeClinical OncologyAnnual MeetingMain BoardStock ExchangeHong Kong LimitedPriority ReviewBreakthrough Therapy DesignationDrug Evaluation
Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference - Vimarsana News

Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference

Published: January 6, 2022

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com
Related Topics:
Hong KongWestern AustraliaDajun YangAscentage PharmaPrnewswire Ascentage PharmaMajor NationalNational Major New Drug DiscoveryChina National Medical Products AdministrationMd Anderson Cancer CenterDana Farber Cancer InstituteStandard TimeHealthcare ConferenceMain BoardStock ExchangeHong Kong LimitedPriority ReviewBreakthrough Therapy DesignationDrug EvaluationOrphan Drug DesignationFast Track DesignationOrphan DesignationMajor National Rd ProjectsNew Drug IncubatorInnovative Drug ProgramsMajor Project